To assess the clinical application value of copy number variation sequencing (CNV-seq) combined with karyotype analysis in prenatal diagnosis of fetuses with increased nuchal translucency. Methods 205 fetuses who were diagnosed with increased nuchal translucency (NT ≥ 2.5 mm) by ultrasound between gestational ages of 11 and 13 + 6 weeks from June 2017 to December 2020 in Tongji Hospital were enrolled. Amniotic uid samples were extracted for performing karyotype analysis and CNV-seq after patient's written informed consent was obtained. ResultsChromosome abnormalities were discovered in 40 fetuses (19.51%) with increased NT by karyotype and the trisomy 21 was the most common. 50 fetuses (24.39%) with chromosomal abnormalities were detected by CNV-seq, producing an incremental yield of 6.06% (10/165) in fetuses with increased NT and normal karyotype. The prevalence of chromosome abnormality increased by from 13.64% for those with NTs of 2.5-3.4 mm to 38.64% for NTs of 3.5-4.4 mm and 51.72% for NTs of over 4.5 mm. The difference had statistically signi cance (P < 0.05). Those with increased NT complicated with ultrasound soft markers or high risk of non-invasive prenatal testing showed higher rate of chromosome abnormality than those with isolated NT or low risk, and difference had statistically signi cance (P < 0.05). ConclusionAs the thickness of NT increases, the odds of chromosome abnormalities also increase, which could be detected by karyotype or CNV-seq, and the combination application of two tests can greatly shorten the turnover time of prenatal diagnosis and the occurrence of missed diagnosis. Besides, we recommend that the NTs of 2.5-3.4mm should be considered as a critical risk range of chromosome abnormality and attention should be paid to those fetuses whether complicated with other ultrasound soft markers or not.
This study introduced whole-exome sequencing (WES) in prenatal diagnosis of fetal bowel dilatation to improve the detection outcome when karyotype analysis and copy number variation sequencing (CNV-seq) were uninformative in detecting pathogenic variants. The work reviewed 28 cases diagnosed with fetal bowel dilatation and analyzed the results of karyotype analysis, CNV-seq, and WES. Among the 28 cases, the detection rate in cases with low risk of aneuploidy was 11.54% (3/26), which is lower than 100% (2/2) in cases with high risk of aneuploidy. Ten low-risk aneuploidy cases with isolated fetal bowel dilatation had normal genetic testing results, while the remaining 16 cases with other ultrasound abnormalities were detected for genetic variants at a rate of 18.75% (3/16). The detection rate of gene variation was 3.85% (1/26) by CNV-seq and 7.69% (2/26) by WES. This study suggested that WES could reveal more genetic risk in prenatal diagnosis of fetal bowel dilatation and has value in prenatal diagnosis to reduce birth defects.
Nowadays, electronic commerce (e-commerce) has brought facilitation to people’s daily lives. Smart-card-based systems are widely used as an implementation, where smart cards act as a secure carrier for small-sized data. However, most of these systems are developed and managed by each service provider individually and repeatedly, which causes both unnecessary work and difficulties in future maintenance. Besides, advantages of smart card technology are not full-fledged for the lack of enough consideration in flexibility and security. To propose a solution, this article presents a Universal Application Storage System, including card side, terminal side, and back-end system. The card side provides a universal and secured infrastructure for data storage, where data are organized and stored in a card file system with several security mechanisms. In the terminal side, a framework for accessing various forms of secure element is presented to simplify the procedures involved in manipulating smart cards. Through this framework, the back-end system is able to establish a direct connection to the card, and performs authorized operations by exchanging commands in a secure channel. The validity of the proposed system is verified at the end of this article, illustrated by an e-coupon system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.